Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says. Watch here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTyratech Regulatory News (TYR)

  • There is currently no data for TYR

Trading Update

23 Jul 2009 07:00

RNS Number : 1435W
TyraTech, Inc.
23 July 2009
Β 

ο»Ώ

For immediate release

23 JulyΒ 2009

There will be a conference call for investors and analysts to discuss this announcement todayΒ atΒ 11:00 (BST). Dial-in details are as follows: UK Access Number: +44 (0)20 8609 1435, US toll free number: 1866 793 4279, PIN code:Β 356088#. A replay of the conference call will be available for one month viaΒ UK:Β 0800 358 2189 or 020 8609 0289, US:Β 1 866 676 5865. Conference reference number:Β 268811#.

TYRATECH, INC.

("TyraTech" or "the Company")

Trading Update

TyraTech, Inc. (AIM: TYR), a leading independent novel clean technology company for human, animal and environmental health,Β todayΒ provides an update on trading for theΒ six month period ended 30 June 2009. The Company will announce its interim results onΒ 16 September 2009.Β 

Product sales for the first half of 2009 continue to grow, supported particularly by the Company's first orders of insecticide by its new partner, Terminix. However,Β the Board anticipatesΒ thatΒ revenues and profits for the full year 2009Β will be significantly belowΒ currentΒ market expectations. CashΒ balancesΒ are expected toΒ beΒ at or nearΒ marketΒ expectationsΒ at year end. The reduction in revenue projection ties to a reduced activity in certain low-margin business areas, and the difficulty in accurately forecasting the size and timing of new orders for the Company's major commercial businesses - notably its commercial partner Terminix and its Sustainable Solutions division - that are otherwise showing material sales growth. Directors' expectations of year end cash levels being near to, or at, current market expectations are due to improved working capital management and close operational management of expenses and have been arrived at, assuming revenue from contracts in hand or which are close to completion.

While additional contracts and orders are expected in 2009, the Company will communicate these developments to the market, when they are accurately known.

TyraTech's main commercial programs are progressing well. The development project with Kraft Foods is on track for 2009 and no reductions in revenue are expected. TyraTech's partnership with Terminix has developed ahead of schedule and has already led to two major product orders, the first of which has been delivered and the second of which is scheduled for the next few weeks. Terminix's marketing of the SafeShield insecticide product is only in the initial stages, and though underway, accurate forecasting of new orders is difficultΒ until some experience is gained.

TyraTech's other partnerships with Arysta and TyraChem are continuing to develop well and the Company will provide guidance to the market as significant changes in revenue expectations occur.

One line of projected business revenue for 2009 was expected though the Company's commercial partner inΒ India. Based on difficulties in getting payments and slow market development of what has been a low margin opportunity, TyraTech will no longer continue this commercial activity, and has included this decision in its revised guidance.

TyraTech'sΒ Sustainable SolutionsΒ business is progressing wellΒ with a significant amount of interest in the division's products. Revenues for the year are largely to come from the sales of its WasteSolver and SolidSolver equipment to dairy farms for effective waste management. Sales have been adversely affected largely due to the price of milk in theΒ USA, which has dropped by 44% since January 2008, and dairy farmers are cautious about taking on new financial commitments. This situation has resulted in a reduction in the projected revenue for 2009. However, the level and rate of completed purchase contracts has increased inΒ late Q2 2009, and the business is expected to show revenue growth through 2009 as new installations are commissioned. TyraTech has engaged advisors to explore bringing in a new strategic investor to further accelerate its rate of growth.

Commenting on the announcement, Douglas Armstrong Ph.D., Chief Executive Officer of TyraTech, said:Β "In 2009,Β TyraTech hasΒ successfully demonstrated a transition from the development state to a growing commercial company with several product lines and market adoption. Revenues are on the rise led by our relationships with Terminix and Kraft Foods, along with the progress in our Sustainable Solutions Division. Our multiple paths of revenue business model is beginning to clearly be demonstrated.

"While the business operations have progressed well, weΒ are cautious about how quickly our markets will expand and we are therefore carefully controlling our costs and working capital investments. We remain positive that we can executeΒ our business plan and strategy and thatΒ there isΒ aΒ potential for high gross margins on products andΒ additional materialΒ payments from partnering and licensing deals. WeΒ believe that we willΒ be able to evidence this progress through announcementsΒ duringΒ the rest of 2009 and we will carefully expand expectations as the business grows into 2010."

For further information please contact:

TyraTech Inc.
Β 
Douglas Armstrong Ph.D., Chief Executive Officer
+1 (321) 409 7723
Keith Bigsby, Chief Financial Officer
+1 (321) 409 7714
www.tyratech.com
Β 
Nomura Code Securities
Β 
Charles Walker / Clare Terlouw
+44 (0)20 7776 1200
www.nomuracode.com
Β 
Buchanan Communications
Β 
Mary-Jane Elliott / Lisa Baderoon
+44 (0)20 7466 5000
/ Catherine Breen / Stasa Filiplic
Β 
www.buchanan.uk.com
Β 

About TyraTech

TyraTech was formed in 2004 to develop and commercialise products for the control of invertebrate pests and pathogens using the Company's proprietary technology. TyraTech, which already has a product on the market, is positioned for human health, animal health and pesticide market opportunities which total over $32 billion globally. TyraTech's technology provides the Company with a wide variety of product and business opportunities in many markets and geographic regions. The differentiating feature of these products is the potential to have a combined level of potency and safety that other invertebrate control products are unable to offer. TyraTech's platform brings many of the principles of drug discovery and development to the fields of insecticides and parasiticides. By targeting specific chemoreceptors that are found in invertebrates but not in humans and animals, TyraTech can produce products that use natural plant derived compounds targeting these receptors.

TyraTech's plan for the use of its technology is to develop selected proprietary active ingredients which can then be used across a wide variety of market segments, either by development partners or by TyraTech itself. TyraTech already has products or partnerships in the areas of professional and horticultural insect control. TyraTech also has an innovative partnership with Kraft to use its natural oils to develop functional foods for improving the health of the more than 2 billion people worldwide subject to intestinal parasitic infections.

TyraTech also has a separate technology with associated intellectual property that is the basis for the Sustainable Solutions business. This technology has been incorporated into specialised dairy farm equipment for processing cattle manure waste to a usable material for TyraTech to sell as a commercial plant growing medium. For more information please visit www.tyratech.com.

###

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
TSTPUUUAMUPBUCW
Date   Source Headline
29th Sep 20107:00 amRNSInterim Results
9th Sep 20109:46 amRNSNotice of Interim Results
25th Aug 20104:50 pmRNSUnrestricted Trading Line Completed
5th Aug 20107:00 amRNSBoard Change
29th Jul 20102:40 pmRNSMajor Interest in Shares
19th Jul 20107:00 amRNSEstablishing Unrestricted Trading Line
9th Jul 201012:41 pmRNSResult of AGM and Board Changes
23rd Jun 20104:06 pmRNSMajor Interest in Shares
22nd Jun 20107:00 amRNSResults for the year ended 31 December 2009
21st May 20105:35 pmRNSDirectors' Disclosure
19th May 20105:15 pmRNSResult of Special Meeting
18th May 20107:00 amRNSUpdate to Fundraising
10th May 20107:00 amRNSFundraising and Trading Update
29th Apr 20107:00 amRNSProspective fundraising of approximately £1m
24th Feb 20107:00 amRNSPreliminary Results
4th Feb 20105:41 pmRNSAward of Share Options
4th Feb 20107:00 amRNSExpanded Terminix Agreement
5th Jan 20107:00 amRNSBoard Changes
24th Nov 20097:00 amRNSTrading Update
11th Nov 20097:00 amRNSDirector Share Purchase
9th Nov 20097:00 amRNSArysta Insecticide Product Launch
5th Oct 20097:00 amRNSKraft Milestone and Contract
21st Sep 20093:41 pmRNSDirector Share Purchase
16th Sep 20097:01 amRNSBoard Changes
16th Sep 20097:01 amRNSChange of Auditor
16th Sep 20097:00 amRNSInterim Results
10th Sep 20097:00 amRNSClarke Partnership
19th Aug 20097:00 amRNSStrategic Partnership Agreement
28th Jul 20097:00 amRNSNew Product Launch
23rd Jul 20097:00 amRNSTrading Update
22nd Jun 20092:03 pmRNSAnnual Report and Accounts
21st May 200912:15 pmRNSAGM Statement
20th May 20097:00 amRNSExpanded Agreement with Terminix
20th Apr 20097:00 amRNSTerminix First Shipment
16th Apr 20096:02 pmRNSDirectors Share Purchase
15th Apr 20096:20 pmRNSDIRECTORS SHARE PURCHASE
14th Apr 20095:44 pmRNSDirectors Share Purchase
9th Apr 20095:17 pmRNSDirector Share Dealings
7th Apr 20095:00 pmRNSCorrected Notice of AGM
1st Apr 20097:06 amRNSPreliminary Results
30th Mar 20097:00 amRNSNew product Launches
20th Mar 20097:00 amRNSNotice of Preliminary Results
27th Jan 20097:00 amRNSShare Buy Back Transaction
16th Jan 20097:04 amRNSOptions Award
16th Jan 20097:02 amRNSShare Buy Back
16th Jan 20097:00 amRNSSalary Reductions
14th Jan 20097:00 amRNSNew Joint Venture - TyraChem
23rd Dec 20087:00 amRNSProgress with Kraft Foods Partnership
24th Nov 20087:00 amRNSAgreement Signed with Terminix
20th Oct 20087:00 amRNSSummons from Molecular Securities, Inc

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.